Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device

Islet transplantation is a successful β-cell replacement therapy for selected patients with type 1 diabetes mellitus. Although high rates of early insulin independence are achieved routinely, long-term function wanes over time. Intraportal transplantation is associated with procedural risks, require...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepper, Andrew R., Pawlick, Rena, Gala-Lopez, Boris, MacGillivary, Amanda, Mazzuca, Delfina M., White, David J. G., Toleikis, Philip M., Shapiro, A. M. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Basic Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623852/
https://www.ncbi.nlm.nih.gov/pubmed/26308506
http://dx.doi.org/10.1097/TP.0000000000000864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623852/
https://www.ncbi.nlm.nih.gov/pubmed/26308506
http://dx.doi.org/10.1097/TP.0000000000000864

Ejemplares similares